Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
Janice Soo Fern Lee1, Alexandra Calmy1,2, Isabelle Andrieux-Meyer1, Nathan Ford1,31Médecins Sans Frontières, 2HIV/AIDS Unit, Infectious Disease Service, Geneva University Hospital, Geneva, Switzerland; 3Centre for Infectious Disease Epidemiology and Research, University...
Main Authors: | Lee JSF, Calmy A, Andrieux-Meyer I, Ford N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-01-01
|
Series: | HIV/AIDS : Research and Palliative Care |
Online Access: | http://www.dovepress.com/review-of-the-safety-efficacy-and-pharmacokinetics-of-elvitegravir-wit-a9042 |
Similar Items
-
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
by: Ford N, et al.
Published: (2011-04-01) -
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
by: Prinapori R, et al.
Published: (2015-08-01) -
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment of patients with HIV and HBV co-infection
by: Y.-S. Huang, et al.
Published: (2019-07-01) -
When to start antiretroviral therapy in resource-limited settings: a human rights analysis
by: Calmy Alexandra, et al.
Published: (2010-03-01) -
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.
by: Josep M Llibre, et al.
Published: (2016-01-01)